20000 Participants Needed

Registry for Rare Diseases

(CoRDS Trial)

Recruiting at 1 trial location
CT
Overseen ByCoRDS Team
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Sanford Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial connects patients with rare diseases to researchers through a centralized patient registry. By enrolling, patients help scientists understand and develop treatments for over 7,000 rare diseases. Those diagnosed with a rare disease, have a disease with unknown prevalence, are undiagnosed, or are unaffected carriers of a rare disease might be suitable for this trial. Joining the registry is free and supports new discoveries and potential cures. As an unphased study, this trial offers a unique opportunity to contribute to groundbreaking research and potentially accelerate the discovery of new treatments.

Do I have to stop taking my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to check with the trial coordinators for more details.

Why are researchers excited about this trial?

Researchers are excited about the Rare Disease Patient Registry & Natural History Study because it offers a new way to gather comprehensive data on rare diseases, which is different from current treatment-focused approaches. Unlike traditional treatments that target symptoms, this registry aims to collect detailed information about the progression and characteristics of rare conditions. By systematically compiling patient data, researchers hope to uncover patterns, identify potential new treatment targets, and improve the overall understanding of these diseases. This could lead to more targeted and effective therapies in the future.

Are You a Good Fit for This Trial?

Inclusion Criteria

Diagnosis of a rare disease, a disease of unknown prevalence, undiagnosed or an unaffected carrier of a rare/uncommon disease

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Enrollment

Participants enroll in the CoRDS registry and provide contact, sociodemographic, and health information

Ongoing

Annual Follow-up

CoRDS contacts participants annually to confirm continued interest and update information

Annually

What Are the Treatments Tested in This Trial?

Interventions

  • Patient Registry

Find a Clinic Near You

Who Is Running the Clinical Trial?

Sanford Health

Lead Sponsor

Trials
53
Recruited
2,067,000+

International WAGR Syndrome Association

Collaborator

Trials
1
Recruited
20,000+

TBX4Life

Collaborator

Trials
1
Recruited
20,000+

Cure DHDDS

Collaborator

Trials
1
Recruited
20,000+

ML4 Foundation

Collaborator

Trials
1
Recruited
20,000+

Lambert Eaton (LEMS) Family Association

Collaborator

Trials
1
Recruited
20,000+

Noah's Hope - Hope4Bridget Foundation

Collaborator

Trials
2
Recruited
120,000+

International Association for Muscle Glycogen Storage Disease (IamGSD)

Collaborator

Trials
1
Recruited
20,000+

Athymia

Collaborator

Trials
1
Recruited
20,000+

Scheuermann's Disease Fund

Collaborator

Trials
1
Recruited
20,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security